Results from animal studies that indicated
sucralose could modify the absorption of glucose in the intestine were not observed when the sweetener was fed to humans, according to findings published in the
British Journal of Nutrition.
Researchers from the University of Adelaide and the Royal Adelaide Hospital also report that consumption of the sweetener did not affect levels of a hormone linked to hunger - glucagon-like peptide-1 (GLP-1).
Previous studies with animals have suggested that sweeteners may interact with glucose and enhance the absorption of glucose in the gut
via GLUT2 expression.
Bangalore-based BioPlus Life Sciences manufactures sucralose using a process it claims does not infringe any of Tate & Lyle's patents and is itself supported by a suite of patents.
Solae said its Cenergy FMS ingredient contains a mixture of protein, soluble and insoluble fibre from the soybean cotyledon – the part of a seed embryo that becomes the first leaves of a seedling. According to the company, the combination of these components results in the ingredient’s ability to control purge, increase water retention and improve cooking yields in ground meat applications.
Results from animal studies that indicated sucralose could modify the absorption of glucose in the intestine were not observed when the sweetener was fed to humans, according to findings published in the British Journal of Nutrition.
